NIFTY  8,896.70  -0.48%
  SENSEX  28,812.90  -0.28%
 CURRENCY  Rs  66.83/$ 70.65/€, 83.79/£
  GOLD  29,717.00  0.32%
  SILVER  43,440.00  0.20%
  DAX  11,822.70  0.16%
  FTSE  7,253.00  0.13%
  CAC  4,845.18  -0.00%
  HANG SENG  23,925.10  -0.17%
  NIKKEI  19,107.50  -0.91%
  Shanghai Composite  3,228.66  -0.42%
  DOW JONES  20,821.80  0.06%
  NASDAQ  5,845.31  0.17%
  S&P 500  2,367.34  0.15%
SANOFI INDIA Q4 - Net Sales At Rs 552 Cr Vs Rs 522 Cr YoY SANOFI INDIA Q4 - Net Profit At Rs 50.5 Cr Vs Rs 120 Cr YoY

Remain Optimistic On Pharma, IT Cos: David Gaud

Video:

Play this video

October 14: Although valuations in pharma and IT space are high, we remain fairly positive on these sectors, says David Gaud, Senior Portfolio Manager at Edmond de Rothschild. There is more upside for these two sectors, he says, adding that funding costs and Indian banks remain a worry.